IDEAYA Biosciences (IDYA) News Today $16.98 -0.13 (-0.76%) As of 01:42 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Ideaya Biosciences announces FDA Type D meeting for darovasertib trial designApril 15 at 5:40 AM | markets.businessinsider.comIdeaya trial design consisent with guidance, says OppenheimerApril 15 at 5:40 AM | markets.businessinsider.comGeode Capital Management LLC Acquires 43,226 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Geode Capital Management LLC increased its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 2.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,988,681 shares of the company's stock after acqApril 15 at 3:40 AM | marketbeat.comIDEAYA Biosciences Announces Successful FDA Type D Meeting on Phase 3 Registrational Trial Design for Darovasertib as Neoadjuvant Therapy for Primary Uveal MelanomaApril 14 at 6:00 AM | prnewswire.comFmr LLC Acquires 327,498 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Fmr LLC lifted its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 2.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,963,151 shares of the company's stApril 13 at 5:24 AM | marketbeat.comExodusPoint Capital Management LP Sells 343,236 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)ExodusPoint Capital Management LP cut its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 86.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,252 shares of the company's stock aftApril 12 at 4:53 AM | marketbeat.comIdeaya Biosciences initiates expansion in IDE397 trialApril 10, 2025 | markets.businessinsider.comIDEAYA Biosciences Announces Phase 1/2 Expansion for IDE397 and Trodelvy® Combination in MTAP-Deletion Urothelial CancerApril 10, 2025 | prnewswire.comIDEAYA Biosciences (NASDAQ:IDYA) Sets New 1-Year Low - Here's What HappenedIDEAYA Biosciences (NASDAQ:IDYA) Sets New 52-Week Low - What's Next?April 9, 2025 | marketbeat.com107,147 Shares in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Acquired by Trexquant Investment LPTrexquant Investment LP bought a new stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 107,147 shares of the company's stock, valued at approximately $2,754,0April 9, 2025 | marketbeat.comNorges Bank Purchases Shares of 520,810 IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Norges Bank acquired a new position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 520,810 shares of the company's stock, valued at approximately $13,385,000.April 9, 2025 | marketbeat.comVanguard Group Inc. Has $130.51 Million Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Vanguard Group Inc. lifted its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 5.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,078,084 shares of the company's stock after purcApril 9, 2025 | marketbeat.comFederated Hermes Inc. Trims Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Federated Hermes Inc. cut its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 2.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,063,526 shares of the company's stock after selling 144,77April 8, 2025 | marketbeat.comRhenman & Partners Asset Management AB Reduces Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Rhenman & Partners Asset Management AB trimmed its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 35.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 82,000 shares of the company's stock afteApril 7, 2025 | marketbeat.comB. Metzler seel. Sohn & Co. AG Invests $701,000 in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)B. Metzler seel. Sohn & Co. AG purchased a new stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 27,276 shares of tApril 7, 2025 | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Sells 30,870 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Mitsubishi UFJ Asset Management Co. Ltd. trimmed its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 81.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,856 sharesApril 5, 2025 | marketbeat.comPrudential Financial Inc. Purchases 18,000 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Prudential Financial Inc. raised its position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 21.4% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 101,935 shares of the company's stock after purchasing an additional 18,000 shares during the peApril 5, 2025 | marketbeat.comIDEAYA Biosciences (NASDAQ:IDYA) Trading Up 4.7% - Still a Buy?IDEAYA Biosciences (NASDAQ:IDYA) Shares Up 4.7% - Time to Buy?April 4, 2025 | marketbeat.comIDEAYA Biosciences (NASDAQ:IDYA) Stock Price Down 7.8% - Time to Sell?IDEAYA Biosciences (NASDAQ:IDYA) Stock Price Down 7.8% - Should You Sell?April 3, 2025 | marketbeat.comLeerink Partners Sticks to Their Hold Rating for IDEAYA Biosciences (IDYA)April 2, 2025 | markets.businessinsider.comWhy Ideaya Biosciences Is Down Despite Many PositivesApril 2, 2025 | seekingalpha.comIDEAYA Biosciences Becomes Oversold (IDYA)April 2, 2025 | nasdaq.comIDEAYA Biosciences Announces Participation in Upcoming April 2025 Investor Relations EventsApril 1, 2025 | prnewswire.comIdeaya Biosciences granted breakthrough therapy designation for darovasertibMarch 31, 2025 | markets.businessinsider.comIDEAYA Biosciences Receives US FDA Breakthrough Therapy Designation for Darovasertib Monotherapy in Neoadjuvant Uveal MelanomaMarch 31, 2025 | prnewswire.comPictet Asset Management Holding SA Acquires 46,931 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Pictet Asset Management Holding SA increased its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 2.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,941,271 shares of the company's stMarch 31, 2025 | marketbeat.comIDEAYA Biosciences (NASDAQ:IDYA) Hits New 1-Year Low - Time to Sell?IDEAYA Biosciences (NASDAQ:IDYA) Sets New 52-Week Low - Should You Sell?March 29, 2025 | marketbeat.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Bought by BIT Capital GmbHBIT Capital GmbH lifted its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 85.0% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 63,672 shares of the company's stock after purchasing an additional 29,259March 28, 2025 | marketbeat.comIDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)March 28, 2025 | prnewswire.comEntryPoint Capital LLC Invests $377,000 in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)EntryPoint Capital LLC purchased a new position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 14,670 shares of the company's stock, valued at approximMarch 28, 2025 | marketbeat.comIDEAYA Announces Oral Presentation at the New Drugs on the Horizon Series at AACR 2025 for IDE275 (GSK959), a Phase 1 Werner Helicase InhibitorMarch 26, 2025 | prnewswire.comSwiss National Bank Buys 16,500 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Swiss National Bank boosted its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 12.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 149,600 shares of the company's stock after aMarch 26, 2025 | marketbeat.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Average Rating of "Moderate Buy" by AnalystsShares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Get Free Report) have received an average rating of "Moderate Buy" from the fifteen brokerages that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation, twelve have issuedMarch 26, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Buys 23,738 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Charles Schwab Investment Management Inc. raised its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 3.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 712,811 shares ofMarch 20, 2025 | marketbeat.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Sold by AlphaQuest LLCAlphaQuest LLC trimmed its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 77.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,661 shares of the company's stock after selliMarch 17, 2025 | marketbeat.comBank of New York Mellon Corp Sells 49,932 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Bank of New York Mellon Corp reduced its position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 18.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 226,299 shares of the company's stock after selling 49,932 shares duringMarch 17, 2025 | marketbeat.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Position Increased by Victory Capital Management Inc.Victory Capital Management Inc. raised its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 8.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 341,063 shares of the company's stock after buying an additional 27,8March 14, 2025 | marketbeat.comIDEAYA Biosciences (NASDAQ:IDYA) Shares Gap Up - Time to Buy?IDEAYA Biosciences (NASDAQ:IDYA) Shares Gap Up - Here's WhyMarch 8, 2025 | marketbeat.comCandriam S.C.A. Grows Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Candriam S.C.A. grew its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 14.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,071,825 shares of the company's stock after acquiring an additional 131,385 shares during the period. CanMarch 7, 2025 | marketbeat.comIDEAYA Biosciences, Inc. (IDYA) Partners with ATTMOS for AI-Driven Drug Discovery PlatformMarch 5, 2025 | msn.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Bought by Fisher Asset Management LLCFisher Asset Management LLC grew its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 3.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 876,599 shares of the company's stock after purchasingMarch 4, 2025 | marketbeat.comIdeaya Biosciences announces research collaboration with AttmosMarch 3, 2025 | markets.businessinsider.comIDEAYA Biosciences Announces Collaboration with ATTMOS to Accelerate AI/ML-Enabled Drug Discovery for Unprecedented First-in-Class Oncology TargetsMarch 3, 2025 | prnewswire.comIDEAYA Biosciences Announces Inducement Grants Under Nasdaq Rule 5635(c)(4)March 2, 2025 | nasdaq.comIDEAYA Biosciences (NASDAQ:IDYA) Reaches New 1-Year Low - Should You Sell?IDEAYA Biosciences (NASDAQ:IDYA) Sets New 12-Month Low - Time to Sell?March 1, 2025 | marketbeat.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Consensus Recommendation of "Moderate Buy" from AnalystsIDEAYA Biosciences, Inc. (NASDAQ:IDYA - Get Free Report) has been given an average rating of "Moderate Buy" by the fifteen research firms that are currently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, twelve have asMarch 1, 2025 | marketbeat.comIDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)February 28, 2025 | prnewswire.comState of New Jersey Common Pension Fund D Boosts Stock Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)State of New Jersey Common Pension Fund D boosted its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 62.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 81,174 shares of the company's stock afteFebruary 23, 2025 | marketbeat.comIDEAYA Biosciences (NASDAQ:IDYA) Sets New 12-Month Low - Here's WhyIDEAYA Biosciences (NASDAQ:IDYA) Hits New 52-Week Low - Here's WhyFebruary 19, 2025 | marketbeat.comBrokers Issue Forecasts for IDYA FY2029 EarningsIDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) - Investment analysts at Wedbush issued their FY2029 EPS estimates for IDEAYA Biosciences in a report issued on Thursday, February 13th. Wedbush analyst R. Driscoll expects that the company will earn $1.20 per share for the year. Wedbush has aFebruary 17, 2025 | marketbeat.com Remove Ads Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Email Address IDYA Media Mentions By Week IDYA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDYA News Sentiment▼1.070.80▲Average Medical News Sentiment IDYA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDYA Articles This Week▼136▲IDYA Articles Average Week Remove Ads Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Legend Biotech News Telix Pharmaceuticals Limited American Depositary Shares News Sarepta Therapeutics News Blueprint Medicines News Axsome Therapeutics News Nuvalent News ADMA Biologics News Krystal Biotech News Grifols News Cytokinetics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IDYA) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IDYA Stock Free IDYA Stock Alerts